News2020-09-24T21:22:26-04:00

Latest News

Groundbreaking Geneticist to Keynote Fasano Longevity Conference

Groundbreaking Geneticist to Keynote Fasano Longevity Conference

Dr. Steve Horvath will deliver the Keynote Presentation on Epigenetics and Biomarkers: A New Age in Longevity Modeling at the November 2nd Fasano Longevity Conference in Washington, DC.

Dr. Horvath, UCLA Professor in Human Genetics and Biostatistics, is the developer of the “Horvath” Epigenetic Clock, a biochemical test that determines the age of body tissues and organs.  His presentation will focus on some of the newer longevity modeling approaches developed from his epigenetic research.

Said Mike Fasano, President of Fasano Associates, “Steve is truly a pioneer in the field of epigenetic research.  Of all the research of the last decade to develop new tools to help measure aging and predict life expectancy, Steve’s work by far offers the most potential.  Anyone with an interest in longevity related investments will want to see his presentation.”

The Fasano Conference is a time efficient, one-day event that covers the most current and relevant topics affecting the longevity markets, and has been favored by the investment and financial community. This year the Conference will be delivered in virtual format, value priced at $195.

Register Now

Conference Registration

Save the Date

Add to Calender

Sponsorship Info

Sponsorship Info

Request Agenda

Request Agenda

Private Equity Perspective on Life Settlements at November 2nd Fasano Longevity Conference

THE 2020 FASANO
LONGEVITY CONFERENCE:

Private Equity Perspective on Life Settlements

Kurt Bolin, Principal at Stone Point Capital, will present his views on the longevity and life settlement markets at the November 2nd Fasano Longevity Conference in Washington, DC.

Stone Point Capital LLC is a financial services-focused private equity firm based in Greenwich, CT. The firm has raised and managed eight private equity funds – the Trident Funds – with aggregate committed capital of $26 billion.  Stone Point targets investments in companies in the global financial services industry and related sectors.

Stone Point Capital has been focused on the life settlement industry for 20+ years.  Mike Fasano, President of Fasano Associates, said: “Private equity firms have a different perspective than hedge funds and other investors.  Kurt Bolin and the Stone Point team have a long track record with insurance and longevity-related assets, and I very much look forward to hearing his insights on the current state of the market.”

The Fasano Conference is a time efficient, one-day event that covers the most current and relevant topics affecting the longevity markets, and has been favored by the investment and financial community. The $495 early bird registration fee includes cocktails and dinner immediately following the Conference.

Register Now

Conference Registration

Save the Date

Add to Calender

Sponsorship Info

Sponsorship Info

Request Agenda

Request Agenda

2020 FASANO LONGEVITY CONFERENCE: BEST VALUE EVER!

THE 2020 FASANO
LONGEVITY CONFERENCE:

BEST VALUE EVER!

  • Its Virtual: No cocktails or dinner this year; but we will make it feel real with live Q&A following every presentation
  • All Substance: Our Agenda this year maintains Fasano’s preeminence in delivering fresh, relevant presentations affecting the longevity markets. Topics will include:
    • Epigenetics and Biomarkers: A New Age in Longevity Modeling
    • COVID-19: Financial, Mortality and Psychological Impact
    • Private Equity Perspective on Life Settlements
    • Outlook for Structured Settlements
    • 2020 Election Predictions
  • Best Value: At $195, the 2020 Fasano Conference is a compelling value!

 

REGISTER NOW!

Register Now

Conference Registration

Save the Date

Add to Calender

Sponsorship Info

Sponsorship Info

Request Agenda

Request Agenda

Over 250 Attend Fasano Longevity Conference to Hear Broad Range of Topics

Flawed Longevity Assumptions – James Rouse

Evaluating Life Expectancy Evaluations – Daniel Bauer, Michael V. Fasano, Jochen Russ & Nan Zhu

The quality of life expectancy estimates is one key consideration for an investor in life settlements. The predominant metric for assessing this quality is the so-called A-to-E ratio, which relies on a comparison of the actual to the predicted number of deaths. In this article, we explain key issues with this metric: In the short run, it is subject to estimation uncertainty for small and moderately sized portfolios; and, more critically, in the long run, it converges to 100% even if the underwriting is systematically biased. As an alternative, we propose and discuss a set of new metrics based on the difference in (temporary) life expectancies. We examine the underwriting quality of a leading U.S. life expectancy provider based on this new methodology.

To view the full article, click the button below.

Structured Settlement Underwriting Performance: Implications for Short Form Life Settlement Underwriting?

This month we are publishing Actual to Expected performance results for our Structured Settlement underwriting business.  The results are good, with an Actual to Expected ratio of 98% for the 2012 through 2016 period, assuming IBNR of 7%.  Without IBNR, the A to E ratio would be 91%.

But the real story here is not the results, but the learning curve behind the results.  When we started underwriting structured settlements in 2007, our initial results were terrible.  We were reviewing files with Attending Physician Statements (APSs) and Paramedical Exams, and our life expectancies were far too long.  We learned that underwriting tools that worked for life insurance and life settlement underwriting do not work in the secondary market for structured settlements.  The demographic of people wanting to convert their structured settlement annuity into a lump sum is different than that of the higher income life insurance and life settlement populations.  First of all, the annuitants typically do not have a regular physician, but rather use the Emergency Room or a walk-in clinic for their medical needs.  So APSs do not provide the same meaningful underwriting information as they do in other insurance related markets.  As important, the types of impairments this population have are frequently behavioral, such as incarceration histories and drug/alcohol abuse, and this information is often not picked up in APSs and paramedical exams.

So we developed a new, streamlined underwriting approach using a Questionnaire targeted to the types of impairments found in the Structured Settlement population, supplemented with prescription drug reports, criminal/driving histories, and telephone interviews.  I think that the results speak for themselves.  But the real story here is that a streamlined, essentially short form underwriting methodology can work.  I think a similar approach could be used for some life settlements; but to be successful it is important to have practical experience and a proven track record, not only in life settlements, but in applying short form underwriting tools.

 

Michael Fasano,
President, Fasano Associates

Fasano Discusses New Tools in Risk Analysis

Fasano Associates President, Mike Fasano, discusses the valuable new medical information that will be available from wearable devices, as well as possible underwriting applications for Big Data analyses.

If you are unable to view this link, please contact us at techsupport@fasanoassociates.com or 202-457-8188.

Contingent Life – Structured Settlements – Fasano Associates Underwriting Methodology

Fasano Associates, a premier life expectancy provider in the life settlement space, has developed a new proprietary mortality table and underwriting methodology for the Life Contingent – Structured Settlement business. View the video below; Fasano Associates President, Michael Fasano, demonstrates and explains the ground breaking underwriting enhancements that have improved life expectancy predictions in the growing structured settlement market.

If you are unable to view this link, please contact us at techsupport@fasanoassociates.com or 202-457-8188.

New Methodology for Measuring Actual to Expected Accuracy Applied to Fasano Database

Drs. Daniel Bauer (Georgia State University) and Jochen Russ (Institute for Actuarial Studies) presented a new methodology for measuring Actual to Expected accuracy at the 9th Annual Fasano Life Settlement & Longevity Conference. The new methodology, Difference in Curtate Life Expectancy (DCLE), calculates the average difference between the actual and expected number of months lived, and is less biased than other methodologies. When applied to the entire Fasano life settlement database, Fasano’s average difference between actual and expected months of survival was less than one month.

Bauer and Russ then sorted Fasano’s DCLE by date of underwriting, as summarized in the following table:

Copies of Drs. Bauer and Russ’ slides are available at www.ifa-ulm.de/downloads/DCLE.pdf. Copies of the subsequent article they published on this methodology are available here.

Poor Underwriting Practices Spark Life Settlement Losses

Rajiv Rebello, a fellow of the Society of Actuaries, a member of the Academy and a Chartered Enterprise Risk Analyst, has written an article titled “Poor Underwriting Practices Spark Life Settlement Losses”. He is a principal of Colva Insurance Services in San Diego. His email address appears at the conclusion of the article. Mr. Rebello’s comment “Discounting historical results in favor of better expectations of future mortality offer life settlement investors a false sense of confidence in the accuracy of the underwriting”, captures the essence of today’s industry discussion. Click here to read entire article.

Michael Fasano Authors Chapter on Life Settlement Underwriting

A Publication for Professional Traders and Institutional Investors.

LIFE MARKETS — Trading Mortality and Longevity Risk with Life Settlements and Linked Securities

Internationally acclaimed expert Vishaal Bhugan, Managing Partner of VB Bhuyan & Co., ‘and a team of coauthors, including Fasano Associates’ President, MICHAEL FASANO, and others from leading financial institutions, hedge funds, actuarial firms, law firms and universities provide a complete analysis of the life settlements market and show how to trade with confidence in the burgeoning market’. Comprehensive in scope ‘Life Markets’ covers a wealth of material touching on everything from the history of life settlements to making a transaction—pricing, service providers, and exchanges.

YOU SHOULD NOT MISS THIS ONE — order your copy directly from the publisher, John Wiley & Sons, Inc.

Michael Fasano Adds Underwriting Expertise to New Book on Reverse Mortgages — Pens Chapter Four on Underwriting Reverse Mortgages

An Institutional Investors Guide to the Burgeoning Field of Reverse Mortgage Securitization.

REVERSE MORTGAGES and LINKED SECURITIES: The Complete Guide to Risk, Pricing, and Regulation by Vishaal B. Bhuyan is a collaborative effort of many of the leading minds in the Home Equity Conversion Mortgages (HECM) industry, including reverse mortgage lenders, institutional investors, underwriters, attorneys and regulators.

Michael Fasano was tapped to share his professional experience from life settlement underwriting and to explain how more sophisticated underwriting could be a boon to the reverse mortgage market.

The book discusses the securitization of reverse mortgages and other linked securities and includes coverage of pricing techniques and risk mitigation, and is one of the only guides to reverse mortgages and linked securities targeted towards institutional investors interested in securitized products.

A MUST READ BOOK —  order your copy directly from the publisher, John Wiley & Sons, Inc.

ALEC – Fasano’s Automated Life Expectancy Calculator

Developed to be used as a SCREENING TOOL for life settlement acquisitions and to assist individuals in financial planning applications. A “user friendly” tool that does not require the assistance of underwriters OR other professionals to complete. Not a replacement for the “real thing” BUT an inexpensive way to assess case value – easy to use while providing good risk discrimination. To try “ALEC”, click on the link in the left sidebar.

Fasano Associates – A Diversified Underwriting Organization

Fasano Associates is a diversified underwriting organization serving the life insurance, annuity/structured settlement, life settlement and related industries.  We have chosen to diversify within the underwriting domain, which has allowed us to leverage our analytic strengths. CLICK HERE to view the entire article.